Archives
-
JNK-IN-7 and Infection-Driven Apoptosis
2026-10-05
JNK-IN-7 provides a selective JNK inhibitor framework for interpreting infection-associated apoptosis without treating all cell-death signals as equivalent. This article connects its covalent kinase mechanism with morphotype-specific findings in Candida krusei-exposed bovine mammary epithelial cells and highlights key evidence limitations.
-
β-NMN and the Next Era of Metabolic Translation
2026-10-05
β-NMN research is moving beyond NAD+ replenishment toward mechanism-aware studies of insulin secretion, mitochondrial signaling, and diabetic cardiac remodeling. This article interprets a 2026 mouse study linking NMN with SIRT3–GSK3β–Smad3 signaling, defines the translational evidence boundary, and explains how beta-Nicotinamide mononucleotide can support rigorous metabolic regulation research without being mistaken for a clinical intervention.
-
Vancomycin and Microbiota–Immune Research
2026-10-04
Vancomycin is a glycopeptide antibiotic with conceptual value in bacterial resistance and microbiota research, but the supplied ulcerative colitis study does not test vancomycin specifically. Its findings support a microbiota–metabolite–immune connection involving Lactobacillus acidophilus and ursodeoxycholic acid, while important limits remain around antibiotic specificity, animal-to-human translation, and clinical applicability.
-
Dimetridazole: From Mechanism to Translation
2026-10-03
A source-grounded perspective on Dimetridazole that connects mechanistic hypotheses, analytical validation, antimicrobial assay design, regulatory context, and translational evidence without overstating what current data prove.
-
Surface Adsorption and Hexetidine Antimicrobial Activity
2026-10-02
Moran and Addy showed that surface adsorption and reactions with chromogenic material can substantially alter the antibacterial activity of cationic antiseptic mouthwashes. Their comparative experiments placed Hexetidine (NSC-17764) in a distinct position: it showed little apparent adsorption to acrylic, yet its activity against Escherichia coli was reduced in the presence of tea and its inhibition zones were eliminated by washing.
-
Measuring Cancer Drug Responses In Vitro
2026-10-01
Hannah R. Schwartz’s dissertation distinguishes relative viability from fractional viability, showing that these measures capture different relationships between proliferative arrest and cell death. The framework provides a more precise basis for interpreting in vitro drug responses and for designing assays that separate cytostatic effects from genuine cytotoxicity.
-
Vancomycin Workflows for Resistance Research
2026-10-01
Translate Vancomycin’s D-Ala-D-Ala binding into reproducible MRSA susceptibility, resistance, and controlled gut-microbiome experiments. This workflow emphasizes stock handling, broth microdilution design, comparator selection, and troubleshooting so antibiotic pressure is not mistaken for an immune or ecological effect.
-
(-)-Blebbistatin: Reliable Assay Workflows
2026-09-30
Learn how (-)-Blebbistatin, SKU B1387, can help distinguish non-muscle myosin II–dependent mechanical effects from genuine cytotoxicity in viability, proliferation, and cardiac assays. This scenario-based guide covers assay compatibility, dosing, solvent control, data interpretation, and practical vendor-selection criteria.
-
DNMT3B and Neuroendocrine Plasticity in Prostate Cancer
2026-09-30
The reference study identifies DNMT3B as a regulator of therapy-associated lineage plasticity, linking neuroendocrine differentiation with stemness in advanced prostate cancer. Genetic suppression and pharmacologic inhibition reduced neuroendocrine prostate cancer growth in preclinical models, supporting DNMT3B as a mechanistically motivated target rather than a passive disease marker.
-
Resazurin Sodium Salt in iPSC Drug Testing
2026-09-29
Resazurin sodium salt provides a redox-based viability readout that can strengthen iPSC-derived airway drug-testing workflows without being mistaken for a direct CFTR function assay. This guide explains how to integrate the fluorogenic oxidation-reduction indicator with multimodal cystic fibrosis models, control metabolic confounders, and improve interpretation.
-
Midecamycin In Vitro Activity: Methods and Findings
2026-09-29
Harold C. Neu’s 1983 study systematically characterized the in vitro spectrum of midecamycin across clinical isolates and compared it with erythromycin, β-lactams, and Vancomycin. The findings show useful activity against many streptococci, staphylococci, Haemophilus influenzae, and Listeria, but limited coverage of Enterobacteriaceae, Pseudomonas, and erythromycin-resistant organisms.
-
Blebbistatin Workflows for Cell Mechanics
2026-09-28
(±)-Blebbistatin enables reversible tests of non-muscle myosin II function in migration, adhesion, and morphology assays. This guide combines concentration planning with a spatially registered imaging strategy inspired by panoramic cardiac mapping, helping distinguish local cytoskeletal effects from global loss of cell health.
-
ZK53 and the Logic of Mitochondrial Stress
2026-09-28
ZK53 is a human mitochondrial serine protease ClpP activator for studying how mitochondrial proteostasis failure reshapes tumor-cell behavior. This article connects its established ClpP-driven effects to a distinct insight from fasting research: separating protein degradation from translational regulation when interpreting mitochondrial readouts.
-
Jasplakinolide Workflows for Actin Research
2026-09-27
Use Jasplakinolide to perturb actin assembly and filament stability in controlled, time-resolved experiments—not as a stand-in for normal cytoskeletal behavior. This practical guide covers titration, imaging, controls, and how to interpret a chemical-genetics study from a separate signaling field without conflating mechanisms.
-
Mechanical Stress–Induced Autophagy Depends on Cytoskeleton
2026-09-26
The study finds that microfilaments are required for compression-induced changes in autophagosome abundance, while microtubules make an auxiliary contribution. By pairing mechanical loading with cytoskeletal polymerization perturbations, it offers a framework for testing how cell structure participates in force-to-autophagy signaling, while leaving the specific molecular pathway and the distinction between autophagosome formation and turnover for further study.